camphorataimide B

04/05/2012 - "In nude mice study, camphorataimide B administration retarded the xenograft tumor growth of MDA-MB-231 cells. "
04/05/2012 - "By immunohistochemical analysis, camphorataimide B decreased the expression of Ki-67 in xenograft tumor in vivo. "
04/05/2012 - "Then we investigated the impact of camphorataimide B on cell survival and cell cycle progression in vitro, and tumor growth in vivo in MDA-MB-231 breast cancer cells. "
04/05/2012 - "Consistent with the cell culture investigation, camphorataimide B also reduced the expression of cyclin-A, cyclin-B1 and COX-2 in xenograft tumor. "
04/05/2012 - "Comparing the cytotoxicity of two synthesized maleimide derivatives in four human cancer cell lines, camphorataimide B displayed potent efficacy. "

04/05/2012 - "Further, camphorataimide B triggered apoptosis and blocked cell cycle progression of MDA-MB-231 breast cancer cells. "
04/05/2012 - "Camphorataimide B decreased the cell viability and foci formation of MDA-MB-231 breast cancer cells. "
04/05/2012 - "Thus, camphorataimide B may play a crucial role in prevention and therapy of malignant breast cancer."
04/05/2012 - "Then we investigated the impact of camphorataimide B on cell survival and cell cycle progression in vitro, and tumor growth in vivo in MDA-MB-231 breast cancer cells. "
04/05/2012 - "Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B."